Previous Close | 4.8300 |
Open | 4.7400 |
Bid | 0.0000 x 800 |
Ask | 0.0000 x 800 |
Day's Range | 4.6600 - 5.0252 |
52 Week Range | 3.6550 - 51.2830 |
Volume | |
Avg. Volume | 1,010,962 |
Market Cap | 337.098M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.1540 |
Earnings Date | Aug 09, 2022 - Aug 15, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 13.25 |
Subscribe to Yahoo Finance Plus to view Fair Value for BLI
Lonza and Edinburgh Genome Foundry to present their high-throughput single-cell screening workflow use cases using the Beacon® PlatformEMERYVILLE, Calif., June 22, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced its participation at the 27th Annual European Society for Animal Cell Technology (ESCAT), being held from June 26 - 29, 2022 at the Lisbon Congress Centre in Lisbon, Portugal. This year’s conference, with the motto, “Advance
A look at the shareholders of Berkeley Lights, Inc. ( NASDAQ:BLI ) can tell us which group is most powerful...
EMERYVILLE, Calif. & ALBANY, N.Y., June 06, 2022--Curia now provides a comprehensive portfolio of state-of-the-art technologies and experience for rapid progression of client antibody programs.